Magnesium for neuroprophylaxis: fact or fiction?

Alison G. Cahill, Aaron Caughey

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The use of magnesium for prevention of cerebral palsy in preterm infants has been a pressing clinical question for some time. This issue was recently brought to the forefront again after the completion of a large trial conducted by the Maternal-Fetal Medicine Units Network and published by Rouse et al in August, 2008 in the New England Journal of Medicine. After review of the complex body of literature on this topic, and the recent addition of this important piece of evidence, we discussed the "pros" and "cons" of the evidence-based use of magnesium for prevention of cerebral palsy at the annual meeting for the Society of Maternal-Fetal Medicine as a luncheon roundtable. The evidence currently available does not make the clinical decision of whether or not to use magnesium for the prevention of cerebral palsy as clear as we would hope. It appears that despite well-designed and executed studies on this critically important topic in obstetrics, the answer to the question of whether evidence-based medicine supports the use of magnesium for neuroprophylaxis in preterm infants remains unclear.

Original languageEnglish (US)
Pages (from-to)590-594
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume200
Issue number6
DOIs
StatePublished - Jun 2009
Externally publishedYes

Fingerprint

Magnesium
Cerebral Palsy
Medicine
Premature Infants
Mothers
New England
Evidence-Based Medicine
Obstetrics

Keywords

  • cerebral palsy
  • magnesium
  • neuroprophylaxis
  • preterm

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Magnesium for neuroprophylaxis : fact or fiction? / Cahill, Alison G.; Caughey, Aaron.

In: American Journal of Obstetrics and Gynecology, Vol. 200, No. 6, 06.2009, p. 590-594.

Research output: Contribution to journalArticle

@article{dc71b27d0e104ae0a13db98be8c1ee31,
title = "Magnesium for neuroprophylaxis: fact or fiction?",
abstract = "The use of magnesium for prevention of cerebral palsy in preterm infants has been a pressing clinical question for some time. This issue was recently brought to the forefront again after the completion of a large trial conducted by the Maternal-Fetal Medicine Units Network and published by Rouse et al in August, 2008 in the New England Journal of Medicine. After review of the complex body of literature on this topic, and the recent addition of this important piece of evidence, we discussed the {"}pros{"} and {"}cons{"} of the evidence-based use of magnesium for prevention of cerebral palsy at the annual meeting for the Society of Maternal-Fetal Medicine as a luncheon roundtable. The evidence currently available does not make the clinical decision of whether or not to use magnesium for the prevention of cerebral palsy as clear as we would hope. It appears that despite well-designed and executed studies on this critically important topic in obstetrics, the answer to the question of whether evidence-based medicine supports the use of magnesium for neuroprophylaxis in preterm infants remains unclear.",
keywords = "cerebral palsy, magnesium, neuroprophylaxis, preterm",
author = "Cahill, {Alison G.} and Aaron Caughey",
year = "2009",
month = "6",
doi = "10.1016/j.ajog.2009.04.003",
language = "English (US)",
volume = "200",
pages = "590--594",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Magnesium for neuroprophylaxis

T2 - fact or fiction?

AU - Cahill, Alison G.

AU - Caughey, Aaron

PY - 2009/6

Y1 - 2009/6

N2 - The use of magnesium for prevention of cerebral palsy in preterm infants has been a pressing clinical question for some time. This issue was recently brought to the forefront again after the completion of a large trial conducted by the Maternal-Fetal Medicine Units Network and published by Rouse et al in August, 2008 in the New England Journal of Medicine. After review of the complex body of literature on this topic, and the recent addition of this important piece of evidence, we discussed the "pros" and "cons" of the evidence-based use of magnesium for prevention of cerebral palsy at the annual meeting for the Society of Maternal-Fetal Medicine as a luncheon roundtable. The evidence currently available does not make the clinical decision of whether or not to use magnesium for the prevention of cerebral palsy as clear as we would hope. It appears that despite well-designed and executed studies on this critically important topic in obstetrics, the answer to the question of whether evidence-based medicine supports the use of magnesium for neuroprophylaxis in preterm infants remains unclear.

AB - The use of magnesium for prevention of cerebral palsy in preterm infants has been a pressing clinical question for some time. This issue was recently brought to the forefront again after the completion of a large trial conducted by the Maternal-Fetal Medicine Units Network and published by Rouse et al in August, 2008 in the New England Journal of Medicine. After review of the complex body of literature on this topic, and the recent addition of this important piece of evidence, we discussed the "pros" and "cons" of the evidence-based use of magnesium for prevention of cerebral palsy at the annual meeting for the Society of Maternal-Fetal Medicine as a luncheon roundtable. The evidence currently available does not make the clinical decision of whether or not to use magnesium for the prevention of cerebral palsy as clear as we would hope. It appears that despite well-designed and executed studies on this critically important topic in obstetrics, the answer to the question of whether evidence-based medicine supports the use of magnesium for neuroprophylaxis in preterm infants remains unclear.

KW - cerebral palsy

KW - magnesium

KW - neuroprophylaxis

KW - preterm

UR - http://www.scopus.com/inward/record.url?scp=65849507273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65849507273&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2009.04.003

DO - 10.1016/j.ajog.2009.04.003

M3 - Article

C2 - 19482112

AN - SCOPUS:65849507273

VL - 200

SP - 590

EP - 594

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -